146 related articles for article (PubMed ID: 12184439)
21. Yellow nail syndrome.
DeCoste SD; Imber MJ; Baden HP
J Am Acad Dermatol; 1990 Apr; 22(4):608-11. PubMed ID: 2319021
[TBL] [Abstract][Full Text] [Related]
22. Physical signs for the general dental practitioner. Case 88. D-Penicillamine rash.
Bain S; Eligar VS
Dent Update; 2011 Oct; 38(8):577. PubMed ID: 22128637
[No Abstract] [Full Text] [Related]
23. Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients.
De La Mata J; Blanco FJ; Gómez-Reino JJ
Ann Rheum Dis; 1995 Nov; 54(11):881-5. PubMed ID: 7492236
[TBL] [Abstract][Full Text] [Related]
24. [Pleuropulmonary manifestations of rheumatoid arthritis].
Gayraud M; Guillevin L
Ann Med Interne (Paris); 1990; 141(5):437-46. PubMed ID: 1979479
[No Abstract] [Full Text] [Related]
25. Yellow nail syndrome in rheumatoid arthritis: report of three cases.
Mattingly PC; Bossingham DH
Ann Rheum Dis; 1979 Oct; 38(5):475-8. PubMed ID: 518148
[TBL] [Abstract][Full Text] [Related]
26. Yellow nail induced by bucillamine.
Ishizaki C; Sueki H; Kohsokabe S; Nishida H
Int J Dermatol; 1995 Jul; 34(7):493-4. PubMed ID: 7591416
[No Abstract] [Full Text] [Related]
27. Yellow nail syndrome: complete triad with pleural protein turnover studies.
Mambretti-Zumwalt J; Seidman JM; Higano N
South Med J; 1980 Aug; 73(8):995-7. PubMed ID: 7403938
[TBL] [Abstract][Full Text] [Related]
28. Yellow nail syndrome--the triad of yellow nails, lymphedema and pleural effusions. A review of the literature and a case report.
Nordkild P; Kromann-Andersen H; Struve-Christensen E
Acta Med Scand; 1986; 219(2):221-7. PubMed ID: 3962735
[TBL] [Abstract][Full Text] [Related]
29. [A rare association: rheumatoid arthritis and the yellow nail syndrome. Report of 2 cases].
Dreno B; Pawlotsky Y; Louboutin JY; Pittie P; Coutard J; Chales G
Rev Rhum Mal Osteoartic; 1981 Oct; 48(10):647-50. PubMed ID: 7302512
[No Abstract] [Full Text] [Related]
30. Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins.
Tóth GG; Jonkman MF
Br J Dermatol; 1999 Sep; 141(3):583-5. PubMed ID: 10583082
[No Abstract] [Full Text] [Related]
31. Thiopronine-induced pemphigus vulgaris in rheumatoid arthritis.
Trotta F; Scaramelli M; Cervi G; Virgili AR
Scand J Rheumatol; 1984; 13(1):93-5. PubMed ID: 6719065
[TBL] [Abstract][Full Text] [Related]
32. A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis.
Kim HA; Song YW
Rheumatol Int; 1997; 17(1):5-9. PubMed ID: 9194208
[TBL] [Abstract][Full Text] [Related]
33. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
Schiff MH; Whelton A
Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
[TBL] [Abstract][Full Text] [Related]
34. Rapidly progressive glomerulonephritis with D-penicillamine.
Nanke Y; Akama H; Terai C; Kamatani N
Am J Med Sci; 2000 Dec; 320(6):398-402. PubMed ID: 11149553
[TBL] [Abstract][Full Text] [Related]
35. Antiarthritic drugs containing thiol groups scavenge hypochlorite and inhibit its formation by myeloperoxidase from human leukocytes. A therapeutic mechanism of these drugs in rheumatoid arthritis?
Cuperus RA; Muijsers AO; Wever R
Arthritis Rheum; 1985 Nov; 28(11):1228-33. PubMed ID: 2998407
[TBL] [Abstract][Full Text] [Related]
36. [Yellow nail syndrome associated with intestinal lymphangiectasia].
Desramé J; Béchade D; Patte JH; Jean R; Karsenti D; Coutant G; Algayres JP; Daly JP
Gastroenterol Clin Biol; 2000; 24(8-9):837-40. PubMed ID: 11011259
[TBL] [Abstract][Full Text] [Related]
37. Yellow Nail Syndrome Associated With Rheumatoid Arthritis.
Taniguchi Y; Kimata T
J Rheumatol; 2021 May; 48(5):785. PubMed ID: 33934081
[No Abstract] [Full Text] [Related]
38. [Respiratory manifestations of yellow nail syndrome: report of two cases and literature review].
Li S; Huang H; Xu K; Xu ZJ
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Mar; 41(3):201-206. PubMed ID: 29518849
[No Abstract] [Full Text] [Related]
39. [Tiopronin-induced nephrotic syndrome with minimal glomerular lesions].
Lecoules S; Duvic C; Hérody M; Nédélec G
Presse Med; 1999 Feb; 28(6):273-5. PubMed ID: 10073167
[TBL] [Abstract][Full Text] [Related]
40. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
